4 false false false false false false false false false false true false false false false false false No description of principal activity 2023-05-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 11323422 2023-05-01 2024-06-30 11323422 2024-06-30 11323422 2023-04-30 11323422 2022-05-01 2023-04-30 11323422 2023-04-30 11323422 2022-04-30 11323422 bus:Director1 2023-05-01 2024-06-30 11323422 core:WithinOneYear 2024-06-30 11323422 core:WithinOneYear 2023-04-30 11323422 bus:Micro-entities 2023-05-01 2024-06-30 11323422 bus:AuditExemptWithAccountantsReport 2023-05-01 2024-06-30 11323422 bus:SmallCompaniesRegimeForAccounts 2023-05-01 2024-06-30 11323422 bus:PrivateLimitedCompanyLtd 2023-05-01 2024-06-30 11323422 bus:FullAccounts 2023-05-01 2024-06-30
COMPANY REGISTRATION NUMBER: 11323422
Mapp E-Clinical Limited
Filleted Unaudited Financial Statements
30 June 2024
Mapp E-Clinical Limited
Statement of Financial Position
30 June 2024
Period from
1 May 23 to
Year to
30 Jun 24
30 Apr 23
£
£
£
Current assets
26,925
57,810
Prepayments and accrued income
3,524
---------
---------
26,925
61,334
Creditors: amounts falling due within one year
2,713
13,402
---------
---------
Net current assets
24,212
47,932
---------
---------
Total assets less current liabilities
24,212
47,932
Accruals and deferred income
565
704
---------
---------
23,647
47,228
---------
---------
Capital and reserves
23,647
47,228
---------
---------
Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the period amounted to 4 (2023: 4 ).
For the period ending 30th June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 18 July 2024 , and are signed on behalf of the board by:
Mr M Watkiss
Director
Company registration number: 11323422
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 109 Borough High Street, London, SE1 1NL, United Kingdom.